AI Article Synopsis
- Epidermal inclusion cysts (EICs) are common skin growths in adults, and there’s a suggestion that smoking might be a risk factor for their development.
- A study analyzed 301 patients with EICs and compared them to a control group, finding that male patients with facial EICs were more likely to be smokers than those in the control group.
- The results suggest a potential link between smoking and the occurrence of EICs, particularly in men.
Article Abstract
Background: Epidermal inclusion cysts (EICs) are a common cutaneous disorder in adults. The etiology of EICs remains obscure. Our clinical experience suggests that smoking may be a risk factor for the development of EICs. OBJECTIVE To determine whether the number and sites of EICs are related to smoking behavior and quantity.
Methods And Materials: We retrospectively surveyed patients pathologically diagnosed with EICs at our hospital. A control group comprised patients who underwent surgical procedures for diagnoses other than EICs. Smoking history was obtained through telephone or clinical interviews.
Results: Three hundred one patients with EICs were identified in our archives: 217 men (mean age 37.1, range 9-77) and 84 women (mean age 41.3, range 9-82). Detailed medical records and smoking history were available for 225 patients. Two hundred twenty-five age- and sex-matched patients were enrolled in the control group. Results showed that a higher percentage of men with facial EICs than of control subjects were smokers (p<.01). No such association was found in women with EICs.
Conclusion: Smoking may contribute to the development of EICs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1524-4725.2010.01565.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Benign eyelid lesions and its histopathological picture: A case-series.
J Family Med Prim Care
December 2024
Department of Ophthalmology, AL-Falah Medical College, Faridabad, Haryana, India.
Our prospective case series evaluates the clinical feature, histopathological picture, and treatment of benign eyelid lesions in a tertiary referral setting. Participants were first nine patients referred to the author with unilateral eyelid swelling. Main outcome measures were clinical features, histopathological picture, and response to surgical intervention.
View Article and Find Full Text PDFEnhanced Wound Healing and Autogenesis Through Lentiviral Transfection of Adipose-Derived Stem Cells Combined with Dermal Substitute.
Biomedicines
December 2024
Department of Plastic Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China.
Background: Burns and chronic ulcers may cause severe skin loss, leading to critical health issues like shock, infection, sepsis, and multiple organ failure. Effective healing of full-thickness wounds may be challenging, with traditional methods facing limitations due to tissue shortage, infection, and lack of structural support.
Methods: This study explored the combined use of gene transfection and dermal substitutes to improve wound healing.
A Retrospective Chart Analysis Comparing Breast Cancer Detection Rates Between Annual Versus Biennial Mammograms.
J Clin Med Res
December 2024
GME Research, Northeast Georgia Medical Center, Gainesville, GA, USA.
Background: Per American Cancer Society, breast cancer is one of the most prevalent causes of cancer-related mortality in women in the United States. Different organizations vary in their recommendations regarding frequency of mammograms, with the United State Preventive Service Taskforce recommending biennial screening and other organizations like American College of Radiology promoting annual screening. The purpose of this study was to analyze institutional data to compare breast cancer detection rates among women undergoing annual vs.
View Article and Find Full Text PDFHealth care resource utilization and costs of Medicare-enrolled patients with HR+/HER2- metastatic breast cancer treated with a CDK4/6i in the first-line setting.
J Manag Care Spec Pharm
January 2025
The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, Department of Pharmacy, University of Washington, Seattle.
Background: The introduction of cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6is) has transformed the treatment landscape for patients with hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-) metastatic breast cancer (MBC). To our knowledge, no studies have quantified health care resource utilization (HRU) or economic burden following CDK4/6i initiation in the Medicare population.
Objective: To describe HRU and quantify health care costs among Medicare-enrolled patients with HR+ HER2- MBC treated with CDK4/6is in the first-line setting.
Cardiac events and dynamic echocardiographic and electrocardiogram changes following osimertinib treatment in lung cancer.
Front Cardiovasc Med
December 2024
Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Osimertinib is first-line treatment for epidermal growth factor (EGFR)-mutated non-small cell lung cancer (NSCLC) and has been associated with cardiotoxicity. However, the nature of cardiac remodeling and associated risk factors remains incompletely understood. Retrospective analysis of NSCLC patients with ≥1 echocardiogram post-osimertinib between 2007 and 2022 was performed.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!